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ABSTRACT 
Each year, interpersonal violence (IV) affects millions of women, causing devastating effects on 
them physically, mentally, emotionally, financially, and socially.  Although mental health 
consequences have long been noted in the literature, the long-term physical health outcomes of 
women who have experienced IV have more recently become an area of interest.  Many health 
conditions previously believed to be unrelated to IV are reported in disproportionate numbers in 
survivors.  One of the most concerning is the increase in cardiovascular disease in women who 
have experienced IV, as cardiovascular disease is the leading cause of death in women 
worldwide.  Of the mechanisms suggested to explain the increased prevalence of cardiovascular 
disease in IV survivors, C-reactive protein (CRP) is of particular interest because it has been 
found to be highly predictive of subclinical heart disease.  We describe some of the long-term 
health consequences of IV and their proposed mechanisms of action.  We then use secondary 
data analysis of the SWAN baseline dataset to examine the relationship between CRP and 
reported IV in the past 12 months.  Specifically, we aimed to examine the relationships between 
CRP, depression, obesity, and smoking for women who indicated IV in the past year.  We also 
aimed to describe the influence of social support and social negativity on CRP, and to explore 
the impact of perception of the severity of the abuse on CRP for these women.  Controlling for 
age and income, our analyses revealed neither IV nor depression were related to elevated CRP, 
but smoking and BMI were.  We also found that social support and social negativity did not 
significantly impact CRP levels.  Clinical and research implications are discussed.  
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CHAPTER 1 
 
INTRODUCTION TO THE PROBLEM 
 Each year, interpersonal violence (IV) affects millions of women worldwide, causing 
devastating effects on them physically, mentally, emotionally, financially, and socially (Black, 
2010; Brown, Finkelstein, & Mercy, 2008; Coker, 2002; Campbell, 2002).  However, numerous 
definitions and perspectives make discerning the impact of interpersonal violence difficult.  Most 
research has focused on the concept of Intimate Partner Violence (IPV), and while definitions of 
intimate partner violence vary, they largely contain similar components.  For example, Saltzman 
et al. defined IPV as completed or threatened physical, sexual, or psychological violence by a 
current or former partner, whereas the Center for Disease Control (CDC) uses IPV to include 
physical violence, sexual violence, stalking and psychological aggression (including coercive 
tactics) by a current or former intimate partner (i.e., spouse, boyfriend/girlfriend, dating partner, 
or ongoing sexual partner)” (Saltzman et al., 2002; Breiding, Smith, Black, Mahendra, 2015).  
However, research on the effects of violence on women’s health also includes physical abuse 
(PA), sexual abuse (SA), psychological aggression/emotional abuse (EA), stalking (S), and rape 
(Lacey, McPherson, Samuel, Sears, & Head, 2013; Krebs, Breiding, Browne, Warner, 2011), and 
not all of these are carried out by Intimate Partners.     
  In this study, we will cast a broad net to examine violence and health by using the 
concept of  interpersonal violence (IV).  We follow the definition given used by the World 
Health Organization (WHO), who define  IV as “acts of violence and intimidation that occur 
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between family members, between intimate partners or between individuals, whether or not they 
are known to one another, and where the violence is not specifically intended to further the aims 
of any group or cause” (Waters, Hyder, Rajkotia, Basu, & Rehwinkel, 2004).   
 Literature suggests that there is significant overlap among types of IV that women 
experience (Krebs, Breiding, Browne, & Warner, 2011), and these types abuse are associated 
with specific health outcomes.  For example, increased rates of depression, and poor health 
perception were found for victims of PA and SA (Bennice, Resick, & Austin, 2003; Bonomi et 
al., 2006; Caetano & Cunradi, 2003, Campbell, 2002; Carbone-Lopez et al., 2006; Coker et al., 
2002; Cortina & Kubiak, 2006; Temple, Weston, Rodriquez, & Marshall, 2007).  Stalking has 
been less studied, but has been associated with depression (Cavanaugh, 2011; Mechanic, 
Weaver, & Resick, 2008).  Furthermore, surviving multiple types of IV over the lifespan have 
been shown to be especially damaging to survivors, suggesting perhaps  a cumulative effect in 
which more types of violence can lead to more negative health outcomes (Basile et al., 2004). 
This hidden interaction is critical because literature may focuse on specific types of IV, or may 
fail to address the impact of multiple traumas in a survivors, or may not account for the extensive 
overlap that can exist between types of violence.  Research has shown that women may 
experience different types of IV within a single relationship, or with different perpetrators over 
the course of her lifetime (Basile et al., 2004; Coker et al. 2000; Garcia-Moreno et al., 2006; 
Miller, 2006; Monnier et al., 2002; Thompson et al., 2006).  For example, in women who 
reported that they had experienced IV-PA as an adult, 31% had also experienced IV-SA and 23% 
had experienced stalking (Miller, 2006).  Marshall et al. found in their study of married women, 
IV-PA and IV-EA were significantly associated with IV-SA (Marshall & Holtzworth-Munroe, 
2002).   
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 In the National Violence Against Women Survey (NVAWS), researchers found a 
significant relationship between all forms of IV (Basile et al., 2004).  This was further 
demonstrated with the National Intimate Partner and Sexual Violence Survey (NISVS Pilot 
Study) (Krebs, Breiding, Browne, & Warner, 2011).  In this study, 96.2 % of women who 
experienced IV-S also reported IV-EA (Krebs, Breiding, Browne, & Warner, 2011).  
Additionally, 86.9 % and 53.2% of women who experienced IV-S reported IV-PA and IV-SA 
respectively (Krebs, Breiding, Browne, & Warner, 2011).   
Significant violence was also been demonstrated among women who experienced 
intimate partner from non-partners (Krebs, Breiding, Browne, & Warner, 2011).  Thirty-one 
percent of women who experienced IV-S additionally experienced sexual violence by a non-
partner, and 29.6% experienced stalking by a non-partner (Krebs, Breiding, Browne, & Warner, 
2011).  Among women who experienced IV-SA, 27.7% also experienced sexual violence by a 
non-partner (Krebs, Breiding, Browne, & Warner, 2011).  Ultimately, Krebs and colleagues 
found that in women who experienced IV-S, SA, and/or PA, nearly all also reported IV-EA. 
 Although mental health consequences of IV have long been noted in the literature, the 
long-term physical health outcomes of women who have experienced IV have more recently 
become an area of interest (Jewkes, Dunkle, Nduna, & Shai, 2010; Beck, Elzevier, Pelger, Putter, 
& Voorham-van der Zalm, 2009; Beck et al., 2009; Jundt, Scheer, Schiessl, Pohl, Haertl, & 
Peschers, 2007; Lesserman, 2007; Frayne et al., 2003; Scott et al., 2013; Sumner et al., 2015). 
Many health conditions previously believed to be unrelated to IV are reported in disproportionate 
numbers in survivors (Beck, Elzevier, Pelger, Putter, & Voorham-van der Zalm, 2009; Woods, 
Hall, Campbell, & Angott, 2008; Lesserman, 2007; Woods et al., 2008).  One of the most 
concerning is the increase in cardiovascular disease (CVD) in women who have experienced IV, 
		
	 4	
especially since CVD is the leading cause of death in women worldwide (NHLBI, 2013; Scott-
Storey, K., Wuest, J., & Ford-Gilboe, M., 2009),  
 Some literature that has examined CVD in women with an IV history has shown that 
overlapping aspects of  a woman’s life can affect her risk of developing CVD (Burns et al., 2015; 
Coutinho et al., 2013; Mehta et al., 2016).  Some research has found that experiencing IV itself 
can increase risk of CVD but also speculate that IV survivors may also develop poor eating 
habits and smoking, which may contribute to CVD (Frayne et al., 2003; Black & Breiding, 2008; 
Bonomi et al., 2006; Bonomi et al., 2009; Bermudez, Rifai, Buring, Manson, & Ridker, 2002; 
AHA, n.d.; CDC, 2008). Finally, depression has been shown to be a consequence of IV as well 
as a CVD risk factor (Elderon & Whooley,	2013;	Glassman, 2008; Whooley, 2006; Nixon, 
Resick, & Nishith, 2004; Daniels, 2005).  Major depression, as well as symptoms of depression, 
have been reported to be risk factors not only for CVD incidence, but also severity of the disease, 
and the outcomes of the disease (Elderon & Whooley, 2013)	
Purpose 
Chapter 2 will examine literature to describe some of the long-term health consequences 
of IV.  Chapter 3 examines literature that explains the mechanisms by which IV and 
inflammation may interact to create risk for CVD.  Of the mechanisms suggested to explain the 
increased prevalence of cardiovascular disease in IV survivors, C-reactive protein (CRP) is of 
particular interest because it has been found to be highly predictive of subclinical cardiovascular 
disease.  Chapter 4 will present the theoretical model that guides this study.  Inspired by Uri 
Bronfenbrenner’s Ecological Systems Theory (EST) (1986). Though the conceptual model used 
here is different from the Bronfenbrenner EST model, it informed the development of our 
conceptual model for the study. 
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  Next, Chapter 5 will describe the methods we used to conduct a secondary data analysis 
of a comprehensive women’s health data set, the SWAN baseline dataset, to examine the 
relationship between CRP and reported IV (Sowers, 2000).   The SWAN dataset assesses 
violence using the question “In the last 12 months have you experienced the following: slapped, 
kicked, or otherwise hurt by husband/partner or someone else important to you?” The addition of 
the phrase “or someone else important to you” supports our use of the WHO definition of IV 
because it takes into account individuals who might not be a current or previous intimate partner.    
Because depression, BMI and smoking are known risk factors for CVD, and are also 
known to be associated with IV, we will use them as covariates (Frayne et al., 2003; Black & 
Breiding, 2008; Bonomi et al., 2006; Bonomi et al., 2009; Bermudez, Rifai, Buring, Manson, & 
Ridker, 2002; AHA, n.d.; CDC, 2008; Elderon & Whooley,	2013;	Glassman, 2008; Whooley, 
2006; Nixon, Resick, & Nishith, 2004; Daniels, 2005).  Our secondary analysis will use CRP as 
our outcome.  We hypothesize that elevated CRP will be associated with IV, depression, 
smoking, and obesity. Recognizing that not all women who experience IV develop elevated 
CRP, or CVD, we propose that the social context in which a woman lives might play a role in 
increasing or decreasing CRP levels.  Therefore, we will also explore the roles of social support 
and social negativity. We hypothesize that women who indicate social support have lower CRP 
and women who have social negativity will have higher CRP.  
The specific aims of this secondary analysis are:  
Aim 1. To examine the relationships between CRP, depression, obesity, smoking, and in 
 women who indicated IV in the past year who have an intact uterus, at least one 
 functioning ovary, pre-menopausal,  and no current use of exogenous hormone 
 preparations that affected ovarian function. 
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Aim 2. To describe the influence of social support and social negativity on CRP in 
 women reporting recent IV.   
Exploratory Aim.  To explore the influence of self-perception of IV on CRP. 
In Chapter 6, the results of descriptive, hierarchical multiple regression and 
multicollinearity analyses for both the entire SWAN data set, as well as a subset that included 
only women reporting a recent history of IV are provided. Finally, in Chapter 7, we conclude 
with a discussion of these results, providing recommendations for future research and practice 
implications.  
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CHAPTER 2  
LITERATURE REVIEW 
 
Interpersonal Violence  
The World Health Organization (WHO) has defined interpersonal violence as “acts of 
violence and intimidation that occur between family members, between intimate partners or 
between individuals, whether or not they are known to one another, and where the violence is not 
specifically intended to further the aims of any group or cause” (Waters, Hyder, Rajkotia, Basu, 
& Rehwinkel, 2004).  Similarly, the International Classification of Diseases (ICD), used 
worldwide to code mortality and morbidity data, grouped together assault, sexual assault, 
neglect, abandonment, and maltreatment as “interpersonal violence” (WHO, 2003).   
According to the Centers for Disease Control (CDC), a current or former spouse, 
cohabiting partner, boyfriend, girlfriend, or date has physically assaulted 22.1% of women in 
their lifetime (CDC, 2012).  Further, researchers suspect that this number underestimates the 
actual number of assaults, because as many as 60% of sexual assaults are never reported to the 
police and underreporting of physical assaults is also extensive (Black et al., 2011).  Researchers 
in the field have long known that IV survivors are at increased risk for depression, anxiety, and 
PTSD, but in the past 10-15 years, it has become increasingly evident that IV adversely affects a 
woman’s physical as well as her mental health (Clum, Calhoun, & Kimerling, 2000).  Current 
evidence suggests that IV may contribute to many chronic physical conditions, including cardiac 
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disease (Jewkes, Dunkle, Nduna, & Shai, 2010; Beck, Elzevier, Pelger, Putter, & Voorham-van 
der Zalm, 2009; Beck et al., 2009; Jundt, Scheer, Schiessl, Pohl, Haertl, & Peschers, 2007; 
Lesserman, 2007; Frayne et al., 2003; Scott et al., 2013; Sumner et al., 2015).  The body of 
literature on the relationship between IV and physical health is vast. The review presented here is 
not a systematic review, but rather a selective representation of English language publications, 
generally carried out in larger samples, or those that were landmark studies. We excluded most 
studies outside of the US, those that are case studies, and qualitative studies.  
Long-term physical health outcomes in Interpersonal Violence survivors 
Multiple studies have shown an association between IV history and adverse physical 
health conditions, suggesting that the history of IV needs to be considered as a risk factor for 
many co-morbidities in women’s health, including vague uro/genital and gastrointestinal 
complaints, severe premenstrual syndrome (PMS), and cardiovascular disease (CVD) (Jewkes, 
Dunkle, Nduna, & Shai, 2010; Beck, Elzevier, Pelger, Putter, & Voorham-van der Zalm, 2009; 
Beck et al., 2009; Jundt, Scheer, Schiessl, Pohl, Haertl, & Peschers, 2007; Lesserman, 2007; 
Frayne et al., 2003; Scott et al., 2013; Sumner et al., 2015).  Additionally, some research has 
suggested that the impact of IV lasts far beyond the experience abuse and may last well after the 
violence has stopped (Dillon, Hussain, Loxton, & Rahman, 2013).  Indeed, the United States 
Preventive Services Taskforce (USPSTF) updated screening recommendations in 2012, 
recommending that screening be done on all women of reproductive age (ages 14-46), and that 
screening can identify women experiencing IV with minimal adverse effects (Nelson, Bougatsos, 
& Blazina, 2012).  The American College of Nurse Midwives has similar recommendations for 
screening asymptomatic women exist for other groups (Paterno & Draughon, 2016). Of 
particular note is the evidence that women with a history of IV are at greater risk for engaging in 
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risky health behaviors such as alcohol and drug use, unprotected sexual activity, and obesity, 
which put them at further risk for multiple co-morbidities (Wingood & DiClemente, 1998; 
Cloutier et al., 2002; Coker, 2007; Sullivan, Cavanaugh, Buckner, & Edmondson, 2009; Meyer, 
Springer, & Altice, 2011; Sullivan, McPartland, Armeli, Jaquier, & Tennen, 2012).   IV history 
is also associated with a poorer self-perception of health, which can lead to increased utilization 
of health care services, a greater number of tests and procedures used to try to diagnose vague 
complaints, and increased time off from work for reasons other than illness (Frayne, Skinner, 
Sullivan, & Freund, 2003; Wittenberg, Joshi, Thomas, & McCloskey, 2007; Bonomi, Anderson, 
Reid, et al., 2009; Black & Breiding, 2008; CDC, 2008).   
Urologic/Gynecologic Conditions 
 In Coker’s 2007 systematic review of the literature, the focus was only on IV-PA.  The 
literature from January 1966-2006 was reviewed and included only articles with a focus on 
sexual health and IV-PA, omitting articles about IV-SA, but acknowledged that various forms 
often co-occur.  Coker cites multiple articles finding pelvic or abdominal pain to be associated 
with IV-PA (Campbell et al., 2002; Campbell & Soeken, 1999; Champion et al., 2001; 
Championet al., 2004; Chapman, 1989; Coker, Smith, et al.,2000; Eby et al., 1995; John et al., 
2004; Schei &Bakketeig, 1989).  Dyspareunia (pain during intercourse) was associated with IV-
PA in eight studies (Campbell et al., 2002; Champion et al., 2004; Champion et al., 2001; 
Chapman, 1989; Golding, 1996; Letourneau et al., 1999; Schei & Bakketeig, 1989).  
Furthermore, many associations were found between dysmenorrheal and vaginal bleeding  
(Champion et al., 2001; Golding, 1996; John et al., 2004; Kovac et al., 2003; Letourneau et al., 
1999; Campbell et al., 2002, and Schei & Bakketeig, 1989).  Each of the studies that looked at 
IV-PA and sexual satisfaction or pleasure found that women who reported IV-PA were 
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significantly less likely to report sexual desire or satisfaction in their intimate relationships 
(Campbell & Soeken, 1999; Garcia-Moreno et al., 2006; Golding, 1996; Kovac et al., 2003). 
Some research has shown that immediately after sexual assault, IV-SA survivors have 
increased problems with urologic and gynecologic health directly related to assault trauma, 
including sexually transmitted infections (STIs) such as human immunodeficiency virus (HIV) 
(Jewkes, Dunkle, Nduna, & Shai, 2010; Kennedy, 2013; Seyller, Denis, Dang, Boraud, Lepresle, 
Lefèvre, & Chariot, 2016).  What is more, these health problems can continue years after the 
assault (Woods, Hall, Campbell, & Angott, 2008).  In one study, researchers examined primarily 
African American female veterans for six gynecological health symptoms: pelvic pain, non-
menstrual vaginal bleeding/discharge, painful intercourse, rectal bleeding, bladder infection, and 
painful urination.  Of the 298 participants in the study, 104 women (39%) had a history of sexual 
assault, with only 39% of the most recent assaults occurring during military service (Campbell, 
Lichty, Sturza, & Raja, 2006).  These survivors were found to have significantly more frequent 
symptoms of all six measures (pelvic pain, non-menstrual vaginal bleeding/discharge, painful 
intercourse, rectal bleeding, bladder infection, and painful urination) after controlling for other 
factors that could affect health status: age, race, education, income, reason for current visit, and 
time since last assault (Campbell, Lichty, Sturza, & Raja, 2006). 
Hilden et al. (2004), in a cross-sectional, multicenter study in five Nordic countries, 
found that chronic pelvic pain and a history of laparoscopic surgery to evaluate pelvic complaints 
was significantly associated with a history of IV with six other conditions showing non-
significant results.  Despite limitations of the research (cross-sectional design, the inability to 
determine the extent to which the symptoms were either related to IV history or to other factors 
in the patient’s life, and the timing of the surgery/symptoms in relationship to the violence 
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experienced), these findings emphasize that pelvic pain is an important concern for practitioners 
(Hilden et al., 2004).    
Golding, Taylor, Menard, and King (2000) studied 42 women from a group of 77 women 
participating in a randomized controlled trial of non-pharmacological treatment for severe PMS.  
They found that 95% of the women had experienced at least one attempted or completed sexual 
assault (Golding et al., 2000).  Though some might question the high rate of assault history in 
this study, Golding et al. (2000) suggested that the strong association can be largely explained by 
the knowledge that the study participants were already participating in a non-pharmacological 
treatment group for PMS and also that sexual assault survivors, as well as women experiencing 
IV, more frequently utilize health care services than non-survivors.  Also, Golding et al. (2000) 
included women with a history of depression, while many other studies exclude people 
diagnosed with depression.  Golding states that this inclusion is important because of the strong 
association between a history of sexual abuse and depression (Golding et al., 2000).   Even 
though Golding et al.’s (2000) study lacked a control group of women without PMS, it still 
suggests that we need to explore IV history for women seeking care for severe PMS.  In addition, 
it is of note that only 18% of participants in this study reported ever having discussed their 
sexual assault history with a health care provider; of those who did, it was the patient who 
brought the issue forth to the provider 73% of the time (Golding et al., 2000).  
Past studies have also suggested bladder dysfunction as a health problem related to IV-
SA.  In a study of 58 sexual assault survivors and 51 controls attending a general gynecology 
clinic, 72% of IV-SA survivors reported ever experiencing urinary incontinence symptoms as 
compared to only 22% of the controls, even controlling for parity (commonly associated with 
incontinence) (Davila, Bernier, Franco, & Kopka., 2003).  Researchers gave participants a self-
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administered questionnaire, and of the 18 symptoms listed, 15 were reported by significantly 
more women who had experienced IV-SA (Davila, et al., 2003).  An association between 
overactive bladder (OAB) and reported IV-SA and IV-PA has also been demonstrated, but no 
association was found for stress incontinence (Jundt, Scheer, Schiessl, Pohl, Haertl, & Peschers, 
2007).   
Interstitial cystitis (IC)	has been shown to be associated with IV-PA, IV-SA, and IV-EA 
in a sample taken from 464 symptom free controls, 215 patients with known IC, and 121 
participants with a health history suggestive of IC (Peters, Kalinowski, Carrico, Ibrahim,  & 
Diokno, 2007).  They found that overall, 37% of participants reporting any type of abuse had IC 
compared with 22% of participants who reported no abuse (P= <0.001) (Peters, Kalinowski, 
Carrico, Ibrahim,  & Diokno, 2007).  Of their participants, 17.7 % reported IV-SA, 31.6% 
reported IV-EA, and 17.2% IV-PA (P= <0.001) (Peters, Kalinowski, Carrico, Ibrahim,  & 
Diokno, 2007).   
Beck et al. (2008) evaluated female patients with pelvic floor complaints seen at a tertiary 
referral center for pelvic floor conditions in order to examine the prevalence of reported sexual 
assault in a large sample of patients with pelvic floor complaints, including complaints related to 
pelvic floor dysfunction, micturition, defecation, and sexual function (Beck, Elzevier, Pelger, 
Putter, & Voorham-van der Zalm, 2009).  The researchers divided 185 patients into 2 groups: 
patients with a history of IV-SA and those without.  The study showed that 23% of the examined 
patients reported a history of IV-SA. Patients with multiple pelvic floor complaints were shown 
to be significantly more likely to have a history of IV-SA than women with only one complaint 
(83% vs. 48%) (Beck et al., 2009).  
In addition to these genitourinary complaints, some IV research has also reported 
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evidence of diminished sexual satisfaction, inhibited arousal, desire dysfunction, and a decrease 
in sexual contact (Van Berlo & Ensink, 2000; Campbell & Soeken, 1999; Garcia-Moreno et al., 
2006; Golding, 1996; Kovac et al., 2003).  Taken together, this body of work shows that 
genitourinary complaints are common among survivors of IV, and should be screened in routine 
primary care.  
Gastrointestinal Conditions 
Women with a history of IV may also experience higher rates of functional 
gastrointestinal impairment, including abdominal or stomach pain (Leserman, Li, Drossman, & 
Hu, 1996; Woods et al., 2008).  For example, a random survey conducted in Minnesota county 
showed that IV survivors experienced twice the episodes of irritable bowel syndrome, dyspepsia, 
and heartburn (Leserman et al., 1998).  These researchers also found that the odds of seeing a 
gastrointestinal specialist were greatest among IV-PA survivors.  IV history was also 
significantly associated with more stomach pain (33% to 13%), nausea (37% to 24), abdominal 
pain (20% to 8%), and painful stools (26% to 14%) (Leserman et al., 1996; Lesserman, 2007). 
Health Related Risk Behaviors Associated with IV 
One of the most modifiable areas of health is risk-taking behavior.  Many studies have 
demonstrated that women with a history of IV have increased rates of risk-taking sexual behavior 
(Cloutier, Martin, & Poole, 2002; Plichta & Falik, 2001; Resnick et al., 1997; Dichter, Cerulli, & 
Bossarte, 2011; Wittenberg, Joshi, Thomas, & McCloskey, 2007; ).  Two studies, in particular, 
showed that women with a history of IV-PA had two-three times more lifetime sexual partners 
than women without IV history (Brown, Wilson, & Kao, 2003; Lang et al., 2003). Brown et al. 
(2003) also showed that the women in their sample who had a history of IV were not only four 
times more likely to have sex with an intravenous drug user, these women also had consensual 
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intercourse for the first time at a significantly younger age.  In a cross-sectional survey of 2823 
nationally representative college undergraduates using the National College Health Risk 
Behavior Survey, Brenner, McMahon, and Warren (1999) found higher risk-taking behaviors, 
including sexual risk-taking.  Their analyses showed that female undergraduate college students 
with a history of IV have higher percentages of the following: use of alcohol or drugs with last 
sexual encounter (22% vs. 12%); multiple sexual partners in the past three months (12% vs. 6%); 
and first sexual intercourse before the age of 15 (21% vs. 9%) (Brenner et al., 1999).  Women 
who had experienced IV-SA were 3 times more likely to have never used condoms, and 2.8 
times more likely to have “never negotiated safe sex” (Wingood & DiClemente, 1998).  Coker 
(2007) found that nearly all studies in her systematic review found that inconsistent condom use 
and partner non-monogamy were significantly associated with IV-PA.  
IV has been strongly associated with smoking, physical inactivity, obesity, and alcohol 
use (Resnick et al., 1997; Cloutier et al., 2002; Frayne et al., 2003; Black & Breiding, 2008; 
Bonomi et al., 2006; Bonomi et al., 2009; Scott-Storey, Wuest, & ford-Gilboe, 2009; McNutt et 
al., 2002; Wittenberg, Joshi, Thomas, & McCloskey, 2007).  The 2008 CDC analysis of the 
Behavioral Risk Factor Surveillance System (BRFSS) for 2005 found positive associations 
linking lifetime IV-PA and high blood cholesterol, history of heart attack, heart disease, current 
smoking, and heavy or binge drinking (CDC 2008).  In a survey of women seeking treatment at a 
San Diego Veterans Administration primary care clinic, the researchers found that a larger 
proportion of women with a history of IV-PA were smokers than non-abused women, 
additionally, women veterans have been shown to have higher rates of IV than the general 
population of women (Lang et al., 2003 Campbell et al., 2003;  O’Campo et al., 2006;  Dichter, 
Cerulli, & Bossarte 2011).  In addition, these participants also tended to smoke more often 
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during pregnancy (Lang et al., 2003).  Similar findings among women veterans were found by 
Frayne et al. (2003), who looked at the possible relationship between IV-PA during military 
service and cardiovascular risk behaviors. They studied a random sample of 3,632 women 
veterans attending any of 158 national Veterans Administration ambulatory care centers.  Results 
from a self-administered questionnaire showed that women with a history of IV-PA had greater 
prevalence of obesity (31% vs. 27%); smoking (44% vs. 29%); problematic alcohol use (13% vs. 
7%); sedentary lifestyle (79% vs. 72 %); and hysterectomy before age 40 (20% vs. 11%) (Frayne 
et al., 2003). 
A telephone survey conducted in 1997 by the North Carolina Behavioral Risk Factor 
Surveillance System found that the likelihood of smoking cigarettes was also increased by IV-
PA (Cloutier et al., 2002).  College women with a history of IV-PA had cigarette smoking rates 
of 39% compared to women who had not experienced sexually assault who had a rate of 25% 
(Brenner et al., 1999).  
Alcohol use may also be a risk behavior that is related to a history of IV. In the National 
Women’s Study, researchers found that 67% of alcoholic women reported a history of abuse 
compared to 4%-20% of non-abused women (Resnick et al., 1997).  Resnick et al. also found 
that drug use rates increased in women with a history of IV-PA, though not to the same extent as 
alcohol (14%-21% of abused women compared with 3%-12% of non-abused respectively).  
Increased alcohol use was also found in the North Carolina BRFSS survey, though alcohol use 
within the past month was not strongly related to IV (Cloutier et al., 2002).  Although Brenner et 
al. (1999) did not find increased rates of binge alcohol drinking in college women with a history 
of IV, they did find increased rates of having driven an automobile or other vehicle after drinking 
(28% vs. 22%). This body of literature suggests that the history of IV has been linked to risk 
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behaviors, and that the presence of these risk behaviors may signal providers to diligently screen 
for history of IV. 
Negative Health Perception Associated with IV 
Some studies have shown that IV is associated with self-perceived poor health (Carbone-
López, Kruttschnitt, & Macmillan, 2006; Tomasuloand & McNamara, 2007).  Data from the 
1998 national, cross-sectional Commonwealth Fund study examined self-rated health status for 
women who experienced IV.  Results showed that women who had experienced IV were 2.8 
times more likely to rate their health as fair or poor than women who had not experienced IV 
(Plichta & Falik, 2001).  In their study of 221 female veterans, Stein et al. (2004) found similar 
results, showing that women with a history of assault had significantly more concerns about their 
health than women who had not been assaulted.  They also found that women with a history of 
IV not only had greater health anxiety, but also had a significantly higher likelihood of having 10 
or more sick days in the previous six months. Additionally, the women in their sample with a 
history IV were significantly more likely to have seen a health care provider more than six times 
in the previous six months (Stein et al., 2004). The North Carolina BRFSS also found that poor 
health perception was more evident in the women with an assault history than in their non-
assault history counterparts (Cloutier et al., 2002).  This research suggests that providers should 
screen general health perception as well as specific complaints. 
Implications of IV on Cardiovascular Health 
Although not immediately thought of as a consequence of IV, a growing body of research 
suggests that IV might increase a woman’s cardiovascular health risks (Cloutier et al., 2002; 
Husarewycz et al., 2014; Scott et al., 2013; Sumner et al., 2015).   The North Carolina BRFSS 
found that victims of IV-PA were more likely than non-victims to have hypertension, high 
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cholesterol, obesity, and smoke cigarettes, all known risk factors for cardiovascular disease in 
women (Cloutier et al., 2002; American Heart Association, n.d.).  In Frayne et al.’s (1999) study 
of female veterans, 26% of female veterans with a history of IV-SA reported cardiovascular 
diseases or risk factors, including self-reported heart attacks, compared to only 11% of their non-
assaulted female peers.  Breiding, Black, and Ryan (2008) defined IV as being threatened, 
attempted, or completed physical or sexual violence, or emotional abuse by a current or former 
intimate partner (IV-PA, SA, or EA).  They found that IV experience was  significantly 
associated high cholesterol (adjusted odds ratio [aOR] = 1.26, 95% confidence interval [CI] 
1.14–1.38), heart attack (aOR = 1.41, 95% CI: 1.13–1.76), heart disease (aOR = 1.75, 95% CI: 
1.45–2.12), stroke (aOR = 1.79, 95% CI: 1.43–2.23)(Breiding, Black, & Ryan, 2008).  Also of 
interest is their finding that while similar associations between IV and health were present in 
both men and women, the associations between IV and high cholesterol, heart disease, and stroke 
were only present in women (Breiding, Black, & Ryan, 2008). 	
Taken together, this literature demonstrates that IV is detrimental to women’s health in 
many ways, including the prevalence of gastrointestinal, gynecological, urological conditions, as 
well as risk-taking behavior, poor health perception, and cardiovascular disease.  Although some 
of the biological implications of IV have been well described in the literature, there are gaps in 
our understanding of the possible causal mechanisms underlying these relationships, why the 
negative impact is so far reaching, the extent of the detriment, how long these risks continue, the 
potential mediators of the harm, and the possible protective modifiers.   
Because cardiovascular disease is the leading cause of death in women, causing one in 
three deaths each year (NHLBI, 2013), we will confine our review of possible mechanisms by 
which IV can increase the risk of cardiovascular disease (CVD).  When looking at CVD in 
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women, much of the literature explored the inconsistencies between men and women looking at 
sex-based differences, as opposed to gender-based differences (Vaccarino et al. 2010).  When 
examining women’s health, there are sex differences (such as hormones, artery size, etc.) but 
there are also gender differences that capture social, interpersonal, communal, and societal 
expectations and roles.  IV is a considerable gender-based issue impacting an estimated one-
quarter to one-half of all women (Black et al., 2011) 
In March 2016, the American Heart Association released a scientific statement about 
women and CVD in which they identified numerous gaps in our knowledge of women and CVD.  
Among them are questions about the mortality disadvantage among young women compared 
with young men; the unique pathophysiological atherosclerotic manifestations among women; 
the causal mechanisms for mechanical complications among women; and the biological, 
pathophysiological, and psychosocial risk factors on CVD development and progression among 
women (Mehta et al., 2016).  Throughout this review, and the secondary data analysis to follow, 
we will begin to look at these gaps in our knowledge. Using history of IV as our focus area, our 
analysis will speak to these gaps because we examine the relative influences of biological, 
pathophysiological, and psychosocial risk factors among women’s well as modifiable factors 
contributing CVD risk.   
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CHAPTER 3 
MECHANISMS BY WHICH IV MAY LEAD TO CVD 
Researchers have proposed several pathways to attempt to explain how IV can influence 
long-term cardiovascular health.  One of the most compelling pathways by which IV might lead 
to cardiovascular disease is inflammation, and evidence is mounting that there might be a causal 
relationship between CVD and C-reactive protein (CRP), a marker of systemic inflammation (de 
Maat & Trion, 2004).  Experts initially thought CVD to be a disease of plaque formation in 
coronary arteries that resulted largely from lipid levels in the blood, but half of all myocardial 
infarctions occur in people with normal lipid levels (Ross, 1999).  During the past decade, it has 
become increasingly evident that inflammation plays a leading role in the development of CVD 
(Ross, 1999; Tracey 1998).  Furthermore, inflammation may play a role not only in CVD, but in 
all stages of atherothrombosis, the pathology that underlies approximately 80% of all sudden 
cardiac deaths (Albert, Ma, Rifai, Stampfer, & Ridker, 2002).   
The mechanism by which inflammation impacts cardiovascular health is complex. Low-
density lipoprotein cholesterol (LDL-C), injury, or infection, trigger leukocytes to bind to 
monocytes at the site of a developing lesion.  Once there, these leukocytes continue to consume 
lipids, lipoproteins, and the monocytes transition to macrophages, then foam cells, and then 
initiate fatty streaks.  At the location of plaque ruptures, more than half of the cells found are 
macrophages—the primary atherosclerotic inflammatory cells (Moreno et al., 1994).  
Simultaneously, other inflammatory cells, including activated T-cells and mast cells, also adhere 
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to the endothelium and contribute to the formation of atherosclerotic lesions, consisting of a lipid 
pool protected by a fibrous cover.  The monocyte-macrophages release proteolytic enzymes that 
degrade the collagen holding the fibrous cover together, making it more likely to rupture, thus 
exposing debris beneath the arterial blood supply, leading to thrombosis.  Smooth muscle cells 
secrete factors that recruit additional monocyte cells to fight the lesion.  This activation of 
smooth muscle cells in the arterial wall can augment the inflammatory response and lead to a 
procoagulant effect (Lefkowitz & Willerson, 2001; Libby & Simon, 2001). The combined 
activation of macrophages, T lymphocytes, and SMCs leads to further cellular mediation, 
including adhesion molecules, cytokines (interleukin-6), growth factors, and chemokines, all of 
which play an important part in atherogenesis (Libby & Ridker, 1999).  Interleukin-6 (IL-6), the 
primary procoagulant cytokine, can lead to more inflammation and coagulation through 
increased plasma concentrations of fibrinogen plasminogen activator inhibitor type, and CRP 
(Devaraj, Xu, & Jialal, 2003). Interleukin-1 (IL-1), tumor necrosis factor (TNF), and CRP 
mediate the attachment of leukocytes to the endothelium (Pasceri, Willerson, & Yeh, 2000; 
Willerson & Ridker, 2004).  Additionally, CRP can also cause monocytes to produce tissue 
factor, a glycoprotein involved in coagulation.   
In addition to these functional pathways, Nitric oxide (NO) has been proposed as a  
vasoactive peptide that aids in the maintenance of vascular tone and is derived from the 
endothelium (Verma et. al. 2002).  NO is reduced at the location of vascular injury, and is 
thought to play a role in all CVD because it inhibits platelet adherence and aggregation, 
suppresses vasoconstriction, reduces the adherence of leukocytes to the endothelium, and 
prevents the proliferation of vascular smooth muscle cells (Verma et al., 2002).  These combined 
actions contribute both to inflammation and thrombotic pathologies, and some evidence suggests 
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that CRP is involved in suppressing NO production as well as bioavailability (Verma et al., 
2002). 
CRP: A Measurement of Inflammation and Indicator of future CVD 	
Of the available biomarkers of inflammation, CRP is the most predictive of future CVD 
(Ridker, Hennekens, Buring, & Rifai, 2000; Willerson & Ridker, 2004).  Ridker et al. (2000) 
evaluated the predictive value of 12 biomarkers in the same cohort of 28,263 post-menopausal 
women: CRP; plasma levels of serum amyloid A; interleukin-6; sICAM-1; total cholesterol; low-
density lipoprotein (LDL) cholesterol; high-density lipoprotein (HDL) cholesterol; the ratio of 
total cholesterol to HDL cholesterol; apolipoprotein A-I; apolipoprotein B-100; Lp(a) 
lipoprotein; and homocysteine.  They found CRP to be the strongest independent predictor of 
future CVD in women, with a relative risk of 4.4 for women in the highest quartile compared to 
the lowest quartile (95% confidence interval) CVD, though serum amyloid A, interleukin-6, and 
sICAM-1 were also predictors (Ridker et al., 2000).  CRP is primarily produced in the liver, in 
response to IL-6, and has historically been considered an inactive, downstream marker of the 
inflammatory cascade.  More recently, however, it has been suggested that CRP may directly 
impact atherogenesis, as discussed above.  CRP binds to and activates complement as well as 
mediates LDL uptake by macrophages (Torzewski et al., 1998; Zwaka, Hombach, & Torzewski, 
2001).  Researchers have also determined that arterial tissue produces both CRP and 
complement, and that together they substantially up-regulate atherosclerotic plaque formation, 
illustrating that CRP might be produced extra-hepatically (Yasojima, Schwab, McGeer, & 
McGeer, 2001).  
Even in women with LDL levels below 130 mg/dl, the recommended levels in primary 
prevention, elevated CRP was a significant predictor of risk (Ridker et al., 2000).  Although 
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during times of acute injury or illness there could be profound spikes in plasma CRP levels, in 
the absence of these spikes, the year to year within-person changes in CRP are similar to 
traditionally used markers such as total cholesterol and systolic blood pressure (Emberson et al., 
2004).   
Moreover, CRP has been found to be predictive of future CVD in both women with and 
without other CVD risk factors, with the effect being most profound among women appearing to 
be low risk at baseline, with elevated CRP demonstrating a four-fold increase in risk in analyses 
of non-smokers with no history of hyperlipidemia (RR=3.9, P= 0.002) (Ridker et al., 1998).  
High CRP was associated with an increased risk of CVD in women with no history of 
hypertension (RR=2.8), P= 0.03), no history of diabetes (RR=4.9), P=0.001), and no family 
history of early onset atherosclerosis (RR=6.6,P=0.001) (Ridker et al., 1998; Wong, Pio, 
Valencia, & Thakal, 2001).   
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CHAPTER 4 
THEORETICAL FRAMEWORK 
 
Ecological Systems Theory (EST), proposed by Urie Bronfenbrenner, provides a 
framework which helps us better understand the interaction between biological, psychosocial, 
and contextual pathways between IVP, elevated CRP and CVD (Bronfenbrenner, 1986).  First 
introduced in 1979, Bronfenbrenner modified the EST over the past 30 years for use in many 
other disciplines and various populations. The ecological model illustrates the many levels of 
influence on an individual’s behavior. Bronfenbrenner’s model consists of concentric circles; 
with each circle influencing the circles within it; and the individual located at the center of all of 
the circles.  Bronfenbrenner conceptualized individual behavior as being influenced by the 
circles surrounding him or her.     
When viewed through the lens of EST, it is apparent that many areas or “circles” in a 
woman’s life will impact her health.  EST proposes five systems: microsystem, mesosystem, 
exosystem, macrosystem, and chronosystem (Bronfenbrenner, 1986).  The microsystem deals 
with the individuals, groups, and institutions with the most immediate impact on a person’s life: 
their family, friends, neighborhood, religion, etc.  The mesosystem is the interactions between 
the microsystems—for example, relationships between family and friends.  The exosystem 
consists of links between a social setting in which an individual does not have an active role and 
an individual’s immediate context, for example how a partner’s work life can impact a woman’s 
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life.  The macrosystem describes the culture in which one lives and how it can impact one’s 
life—for example how a society or culture views IV survivors, people struggling with obesity, 
smokers, mental illness, etc.  The chronosystem explains the impact of the passage of time on 
one’s life.   
Using the EST perspective as an inspiration for understanding the influences of IV on the 
health of a survivor, we propose three pathways by which women might move from a healthy 
state to a state of inflammation and CVD: psychosocial/mental health;  risk behaviors (smoking, 
unhealthy diet);  and the experience IV itself.  Given this perspective, the social context in which 
a woman lives may both mediate and moderate her CVD outcomes.  Consideration of these 
variables in the secondary analysis will help better understand this inter-relationships. 
Psychosocial/Mental Health 
Research has shown a concerning relationship between depression and CVD.  For 
example, Low, Thurston, and Matthews’ 2010 review found that in 15 separate studies, 
depression was linked to CVD in women 75% of the time.  Frighteningly, in the Nurses’ Health 
Study (NHS), depression was associated with fatal (but not non-fatal) cardiovascular events in a 
fully adjusted model (Whang et al., 2009).  Further, some literature has proposed a relationship 
between PTSD and/or depression and CVD in trauma survivors (Sumner et al., 2015).  In 
addition, it has been suggested that women with a history of trauma who do not report PTSD 
symptoms might be utilizing coping strategies such as suppression, avoidance, or 
compartmentalization, all of which may cause physical distress and lead to negative health 
outcomes (D’Andrea, Sharma, Zelechoski, & Spinazola, 2011).  While all the mechanisms 
connecting mental health conditions to CVD are not yet known, Kendall-Tackett (2007) 
suggested that the cardiovascular affects might be related to the sequela of depression, sleep 
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disturbance, and hostility associated with IV that cause a prolonged cytokine pro-inflammatory 
response resulting in increased risk.  Marital stress may also be a factor, since some research has 
found that it may be atherogenic (Gallow et al., 2003). Woods et al. (2005) proposed a bio-
psycho-immunologic theory similar to Kendall-Tackett (2007) linking trauma to an elevation of 
stress, which in turn triggers inflammatory responses in the body resulting in chronic pain.  
Further, several studies have shown that depression may play a role in subclinical CVD, with 
multiple studies confirming the association (Everson, Kaplan, Goldberg, Salonen, & Salonen, 
1997; Matthews, Raikkonen, Sutton-Tyrrell, & Kuller, 2004; Stewart, Janicki, Muldoon, Sutton-
Tyrrell, & Kamarck, 2007).   
Risk Behaviors 
As discussed above, a relationship exists between IV and health behaviors that are known 
to be cardiovascular risk factors, most notably smoking and obesity.  In addition to the 
understanding that smoking and obesity are known to be cardiovascular risk factors, evidence is 
mounting that they are also involved in CRP elevation (Visser, Bouter, McQuillan, Wener, & 
Harris, 1999; Van Gaal, Mertens, & Christophe, 2006; Aronson et al. 2004; Ohsawa et al., 2005).   
Cerhan and colleagues found that when women have no other identifiable risk factors for 
CVD, waist circumference was associated with a significantly greater risk of mortality compared 
with all other study variables (Cerhan et al., 2014).  Women with metabolic syndrome have been 
shown to have higher prevalence of subclinical CVD as well as higher CVD mortality compared 
to women without metabolic syndrome (Shaw et al., 2006).  More recently, it has been shown 
that people who are obese also have elevated CRP levels, even in the absence of metabolic 
syndrome (Visser, Bouter, McQuillan, Wener, & Harris, 1999; Van Gaal, Mertens, & 
Christophe, 2006; Aronson et al. 2004).  There is a growing body of evidence suggesting that 
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adipose tissue itself is a significant regulator of inflammation, as it produces proinflammatory 
cytokines, including tumor necrosis factor and interleukin- 6, with interleukin-6 being the chief 
stimulator of CRP production (Yudkin, Stehouwer, Emeis, & Coppack, 1999; Heinrich, Castell, 
& Andus, 1990).  Furthermore, research has shown an independent relationship between central 
adiposity and insulin resistance with CRP levels, thus suggesting that chronic inflammation is an 
important component of metabolic syndrome as well as a mediator of the cardiovascular effects 
of the syndrome (Pannacciulli et al., 2001).  
In all age categories, one study found that women who smoke had a significantly higher 
risk of CVD than women who did not smoke, with the largest risk difference in women aged 40-
49 (Tolstrup et al., 2014).  An independent association between smoking and inflammatory 
markers has been demonstrated apart from other known cardiovascular risk factors (Bermudez, 
Rifai, Buring, Manson, & Ridker, 2002).  In current smokers, significant CRP elevation has been 
demonstrated, but not in a dose-dependent way, which means that the number of cigarettes 
smoked per day did not change the analysis, nor did controlling for confounders (Ohsawa et al., 
2005).  Bermundez et al. (2002) conducted multivariate analyses adjusting for traditional 
cardiovascular risk factors and additional factors, including age, BMI, history of hypertension, 
diabetes, alcohol use, physical activity, parental history of myocardial infarction before age 60, 
hormone replacement therapy, HDL, and LDL.  They found that, even after controlling for all 
those factors, inflammatory markers, including CRP, remained elevated in women who were 
smokers, suggesting a relationship between smoking and inflammation in otherwise healthy 
appearing women (Bermundez et al., 2002).   
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Interpersonal Violence 
One study found that when traditional cardiovascular risk factors are controlled for, an 
association may still exists between IV and CVD (Frayne et al., 2003).  Several studies have 
suggested that IV leads to CVD because of the sequela of psychosocial or mental health 
conditions a woman might experience as a result of an IV, but even in the absence of PTSD, IV 
history has been shown to negatively impact physical health—including CVD—and IV history is 
associated with physical health outcomes independent of psychopathology (Husarewycz et al., 
2014; Scott et al., 2013).  This was also demonstrated by Sumner et al. (2015), who showed 
increased CVD risk in women with IV history who reported no symptoms of PTSD.  In women 
with a history of CVD, one study showed that among women aged 30-62 years who reported 
severe marital stress there was a three-fold greater likelihood of recurrent coronary event over a 
four-year follow up, compared to women not reporting marital stress, after other variables were 
controlled for (Orth-Gomer et al., 2000).  Still, little work has been done on the relationship 
between trauma in adults and inflammation, when PTSD is controlled for (Sumner et al., 2015; 
Danese et al., 2007; Dekaris et al., 1993).   
Many studies have focused on childhood trauma (Carpenter et al., 2010; Kiecolt-Glaser et 
al., 2011; Danese et al., 2007).  Danese et al. (2007) demonstrated that, when exposed to two or 
more forms of severe maltreatment during childhood, participants had significantly higher levels 
of CRP in adulthood.  Perhaps most significant to the current project is the 2012 work of 
O’Donovan and colleagues in the Heart and Soul Study, which looked at a prospective study of 
patients with stable CVD (N=979) and examined if higher lifetime trauma exposure was 
associated with elevated levels of inflammation (including CRP) at baseline and follow-up 
(O’Donovan, Neylan, Metzler, & Cohen, 2012).  Even after adjusting for sociodemographic 
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factors and psychiatric disorders, their findings demonstrated that higher trauma exposure was 
associated with elevated inflammation both at baseline and at five-year follow-up (O’Donovan et 
al., 2012).  Though types of trauma were not limited to IV-related trauma, a significant number 
of the measured traumas could be included in our definition of IV.  Most strikingly, the 
Stockholm Female Coronary Risk Study demonstrated that reported marital stress, nearly tripled 
the risk for recurrent cardiac events in women (Orth-Gomer et al., 2000).  While it is unknown 
whether marital stress is present in families that have IV, we believe that this is likely.  Mason et 
al. used the Nurses’ Health Study to study emotional abuse, finding a significant association 
between emotional abuse and hypertension, particularly when the abuse was most severe 
(Mason, Wright, Hibert, Spiegelman, Forman, & Rich-Edwards, 2012). 
Social Context 
Literature has beginning to explore what might moderate the relationship between 
women and CVD including social support or lack of social support (Low, Thurston, & Matthews 
2010; Everson-Rose & Lewis, 2005; Kranz & McCeney, 2002; Suls & Bunde, 2005).  In these 
studies, social support is defined to include not only the structure of a person’s social life (family 
relationships, friendships, group membership), but also the functions that they serve (emotional 
support or assistance in times of illness) (Cohen, Underwood, & Gottlieb, 2000).  Some of this 
literature suggests that, for women, social relationships that are positive and reciprocal may be an 
important part of primary and secondary CVD prevention, whereas stressful interpersonal 
relationships may be a chief risk factor (Low, Thurston, & Matthews, 2010; Suglia, Sapra, 
Doenen, 2015).  Coker and colleagues found that social support moderated the impact of 
battering on women’s mental and physical health, even in the absence of help seeking, 
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suggesting that emotional or social support is key to improved coping with IV (Coker, Watkins,  
Smith, & Brandt, 2003).   
Research has proposed two major pathways to explain the association between social 
support and health. The first suggestion is that social support is health-promoting because it 
encourages healthier behaviors in regards to exercise, diet, smoking, physical activity, following 
healthcare provider advice, etc. (Uchino, 2004).  The reasons for this positive effect might be 
direct (i.e. going for walks, sharing meals, or sharing information), or indirect, such as giving 
people a sense of meaning or purpose in life (DiMatteo, 2004; Lewis & Rook, 1999; Umberson, 
1987).  The second pathway focuses on psychological processes connected to emotions, thought 
processes, or moods, and feelings of control (Cohen, 1988; Gore, 1981; Lin, 1986).  Though 
Barrera (2000) demonstrated the link between social support and psychological process, there is 
little evidence demonstrating their impact on health outcomes (House, 2001).  It is important to 
keep in mind that there is significant interaction between these two pathways in that feelings of 
stress or depression might negatively impact health promoting practices, and health behaviors 
such as exercise can have considerable influence of depression and stress (Ng & Jeffery, 2003; 
Rejeski, Thompson, Brubaker, & Miller, 1992). 
The mechanisms underlying the influence of social support or social negativity is still 
largely unknown, but here too, inflammation appears to play a role.  For example, both human 
and animal models have shown that inflammatory markers such as IL-6 (a precursor to CRP) are 
increased with social stress, and are decreased with social support (Kiecolt-Glaser et al., 2003; 
Papanicolaou, Wilder, Manolagas, & Chrousos, 1998; Zhou, Kusnecov, Shurin, DePaoli, & 
Rabin, 1993).  This was demonstrated again by Friedman et al. (2005), who reported that lower 
IL-6 levels were predicted by more positive social relations.   
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Taken together, we can appreciate the importance of social context on health.  This 
understanding of the importance of social support in women’s health in general, and its 
protective effects after IV, can aid not only in identification of women at risk for CVD, but might 
also foster the development of interventions to reduce risk.  Studies have shown that low levels 
of social support were associated with increased risk for recurrent cardiovascular events as well 
as mortality (Horsten, Mittleman, Wamala, Schenck-Gustafsson, & Orth-Gomer, 2000; Rudlege 
et al., 2004).  Emotionally supportive relationships have been shown to be cardioprotective, and 
conversely low levels of emotional support have been shown to increase risk of CVD (Uchino, 
Cacioppo, & Kiecolt-Glaser, 1996).   
Conceptual Model 
As we have seen, this review supports the propositions that IV may play a role in the 
development of CVD in women, that this interaction may be related to increased levels of CRP, 
and social context may play a moderating role in these interactions.  Our conceptual model 
depicts only the microsystem, or innermost ring, with social context being a component of the 
assumed outer rings because the social context scales used in our analysis include not only the 
mesosystem and exosystem, but also the macrosystem.  To help understand these interactions, 
we have developed a conceptual model to illustrate the relationships between IV, risk behaviors, 
mental health, and social context impacting CRP and leading to CVD (see figure 1).  Because the 
focus of our study was to explore how social support and social negativity influence CRP, we did 
not differentiate between which system the social support or social negativity might reside in.  
This figure illustrates that the progression from IV to CVD can take three paths, all of which 
involve CRP elevation.  An IV survivor might move directly to elevated CRP, without any 
known mental health or risk behaviors.  Or, an IV survivor might move from IV to mental health 
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conditions, to CRP elevation.  Finally, she might develop unhealthy risk behaviors that lead to 
elevated CRP.  Consistent with the EST, all of this happens within a specific social context; in 
other words, a woman’s health is heavily influenced, in both positive and negative ways, by her 
environment.   
Most importantly, the arrows between the social context and the pathologies involved in 
the progression are bi-directional, indicating significant interaction between them in both 
directions. For example, psychological distress may influence a woman’s perception of social 
support or negative social interactions as well as impact her willingness to accept any social 
support that is offered.  Similarly, society’s perceptions of mental health, risk behaviors such as 
smoking or obesity, and IV might influence willingness to offer social support.   
. 
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CHAPTER 5 
METHODS 
 In this secondary analysis, we explore the relationship between IV and CRP, including 
various pathways through which IV might lead to elevated CRP.  Further, we will explore the 
potential contribution of the social context in which a woman exists on CRP.  
Hypothesis 1:  There will be an elevated CRP associated with IV, depression, smoking, and 
obesity in the women in the SWAN study (intact uterus, at least one functioning ovary, pre-
menopausal, no current use of exogenous hormone preparations that affected ovarian function). 
 Aim 1. To examine the relationships between CRP, depression, obesity, smoking, and in 
 women who indicated IV in the past year who have an intact uterus, at least one 
 functioning ovary, pre-menopausal,  and no current use of exogenous hormone 
 preparations that affected ovarian function.   
Hypothesis 2: Social support is associated with lower CRP, social negativity is associated 
 with higher CRP.  
 Aim 2. To describe the influence of social support and social negativity on CRP in 
 women reporting recent IV.   
 Exploratory Aim .  To explore the influence of self-perception of IV on CRP. 
Study design 
 This is a secondary analysis of baseline data from the Study of Women’s Health Across 
the Nation (SWAN), a multi-site longitudinal cohort, epidemiologic study developed to examine 
the health of women during their middle years.  Enrolled women are followed annually.  
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Psychological, biological, and social variables are examined with the goal of helping scientists, 
health care providers, and women learn how experiences during this life stage impact health as 
well as quality of life.  Specific areas of inquiry for SWAN include: bone mineral density and 
body composition; cardiovascular risk factors and measures; ovarian markers; vaginal, 
urogenital, and sexual health; physical functioning; sleep; psychosocial factors; 
pharmacoepidemiology; epidemiologic issues.  After baseline, 15 follow-up visits have been 
held and take place approximately every year.  Each annual visit includes: physical measures 
(weight, height, hip, waist, and blood pressure), fasting morning blood draw, interviewer-
administered and self-administered questionnaires.  Women are also given menstrual calendars 
to complete monthly over the next year, and all questionnaires are translated into Spanish, 
Cantonese, and Japanese and could be administered by bilingual interviewers.  SWAN visits now 
additionally include two bone mineral density (BMD) measurements for women participating in 
the BMD protocol.  In addition to the annual visit core components listed above, new measures 
of physical function, physical activity, sleep, cognition, and vaginal, urogenital, and sexual 
health have been added.  SWAN is supported by the National Institute on Aging (NIA), the 
National Institute of Nursing Research (NINR), the National Institutes of Health (NIH), Office of 
Research on Women’s Health, and the National Center for Complementary and Alternative 
Medicine  (Sowers et al., 2000).   
Sample 
 Study recruitment for the SWAN began in 1994, with recruitment from 1995-1997. 
Recruitment for the SWAN study was 2-stage, beginning with a 15-minute cross-sectional 
survey (utilizing both telephone and face-to-face interviewing) at seven research centers.  Three 
sites used random-digit dialing and four sites used community census or lists of community 
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members such as voter registration lists.  This wave of recruitment identified 16,065 potential 
participants and served as the sample population for the second stage of recruitment.  In total, 
3,302 participants were enrolled for prospective follow-up.  Five racial/ethnic groups are 
represented, as well as a variety of socioeconomic backgrounds and cultures.  
Inclusion criteria for study participation included age 42 to 52 years, intact uterus and ≥1 
ovary, no current use of exogenous hormone preparations that affected ovarian function, ≥1 
menstrual period in the 3 months before enrollment, and self-identification with the site's 
designated race/ethnic group. Three thousand three hundred two women formed the longitudinal 
cohort, with each clinical center expected to recruit ≥450 women in a proportion that included 
both non-Hispanic Caucasian women and women from 1 of the race/ethnic groups designated for 
specific sites.  Each site also screened at least one racial/ethnic minority population (African 
Americans in Pittsburgh, PA; Boston, MA; Detroit, MI; and Chicago, IL; Japanese in Los 
Angeles, CA; Chinese in Oakland, CA; and Hispanics in Newark, NJ) and one Caucasian 
population (Sowers et al., 2000).  Data were collected via protocols reviewed and endorsed by an 
appropriate institutional review board at each site.  
The sample used in this study was 2,502 participants, after inclusion and exclusion 
criteria were met.  The inclusion criterion for this secondary analysis was the same criteria for 
the SWAN study, discussed above.  For our analysis, we excluded participants with a history of 
lupus or arthritis because they are known to be associated with elevated CRP (Williams, 
Harmon, Burlingame, & Du Clos, 2005; Windgassen, Funtowicz, Lunsford, Harris, & Mulvagh, 
2015).  In addition, cases with missing data were excluded.  Further, we analyzed a subset data 
of women who reported IV in the last year. 
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Measures 
  As depicted in the conceptual model (figure 1), the study will look at the relationship 
between IV, mental health, and risk behaviors with CRP, as well as the influence of social 
support and social negativity.   
   Table 2 describing the variables and measures used in this analysis.  In this study, IV 
was operationalized into a dichotomous variable of “yes” or “no” including all women who 
answered “yes” to the question  “In the last 12 months have you experienced the following: 
slapped, kicked, or otherwise hurt by husband/partner or someone else important to you?” 
Response options included “no”, “yes, I wasn’t bothered by it”, “yes, I was somewhat bothered 
by it”, “yes, I was very bothered by it” (see Appendix C: IV scale).  While not specified by the 
authors, this question might come from the Abuse Assessment Scale, which is a 5 question, 
validated scale that includes a question very similar to the question asked in the SWAN study 
“Within the last year, have you been hit, slapped, kicked, or otherwise physically hurt by 
someone? If yes, by whom? How many times?” (Rabin, Jennings, Campbell, & Bair-Merritt, 
2009).   
 Mental health was operationalized as depression, and was measured using the CES-D 
depression scale, which is a 20-item validated measure that asks about frequency of depressive 
symptoms (see Appendix C for CES-D scale) (Radloff 1977).  The CESD is the most commonly 
used measure of depression in studies of IV, and has good validity and reliability with women in 
the general population as well as with women with IV history (Davies, Ford-Gilboe, Willson, 
Varcoe, Wuest, Campbell, & Scott-Storey, 2015).  The scale measures depressive symptoms 
during the past week, with participants giving responses ranging from zero (“rarely” or “none of 
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the time”) to three (“most of the time”).  Scores are summed, with a range from 0-60.  A score of 
16 or higher indicates potential clinical depression, therefore depression was operationalized as a 
CES-D score of 16 or higher.  
 In this study, risk behaviors were operationalized as BMI and self reported smoking.  
BMI was calculated using height (centimeters) and weight (kilograms) and was calculated by 
dividing weight by the square of height in meters.	(kilograms/square meters).  Normal BMI is 
considered to be between 18.5-24.9, with individuals lower than 18.5 considered underweight.  
People with a BMI between 25-29.9 are considered overweight, and greater than 30 is considered 
obese (Coutinho et al., 2013).  For our analysis, we used BMI as a continuous variable to more 
clearly look at associations between CRP and BMI. 
 Smoking was self-reported, by answering “yes” to both “have you ever smoked 
regularly” and “ do you currently smoke”.  Participants who answered “yes” to both questions 
were recoded into “smokers” and participants who answered “no” to both questions, or only 
answered “yes” to one question were recoded as “non-smokers”. 
 Social support was operationalized using four items from the Modified Medical 
Outcomes Study (mMOS) Social Support Survey subscale that assessed how often each of four 
kinds of support was available, if needed (see Appendix C: social support scale) (Sherbourne & 
Stewart, 1991; Moser, Stuck, Silliman, Ganz, & Clough-Gorr, 2012).  The scale ranges from 1-5 
indicating how frequently someone might be available to assist a participant and included 
questions about things like having someone to confide in.  The items were recoded to a 0-4 
range.   
 Social Negativity operationalized using a ten-item questionnaire (see Appendix C: social 
negativity scale) assessing the frequency of negative experiences a woman might encounter in 
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daily life and included questions about things like “you are treated with less respect than other 
people”.  Items were recoded so that lower frequency (“never”) was scored 0 and higher 
frequency (“often”) was scored 4. To the best of our knowledge, this scale was developed by the 
SWAN study team.  
 CRP was operationalized using an ultra-sensitive rate immunophelometry (Dade-
Behring, Marburg, Germany) test on serum collected during the SWAN intake visit and 
measured in mg/L (Burns et al., 2015).  The American Heart Association uses CRP levels <1, 1-
3, and >3 to indicate low, moderate, and high-risk groups for future cardiovascular disease, 
though we kept CRP continuous for our analysis to allow us to look at correlations more closely 
(Ridker, 2003).   
 We determined our covariate variables based on the literature a priori , controlling for  
race/ethnicity, age, and income level in all of our analyses, because they have all been 
demonstrated to elevate CRP (Albert, Buring, & Ridker, 2004; Wener, Daum, & McQuillan, 
2000).  
Statistical Analysis 
 Descriptive, hierarchical multiple regressions, and multicollinearity analyses were 
performed using SPSS for Windows Version 23.   We performed independent t-tests to compare 
means of continuous variables and chi-square tests for categorical variables.  We controlled for 
age, race/ethnicity, and income in all analyses.  To test both hypotheses, analyses were done on 
both the entire SWAN data set, as well as a subset that included only women reporting a recent 
history of IV. For hypothesis 1, hierarchical multiple regressions were done looking at the 
relationships between IV, depression, BMI, and smoking on CRP for the entire sample as well as 
the IV subsample. We tested each variable individually and then in a single model to look for a 
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combined effect.  To test hypothesis 2, we used hierarchical multiple regressions to look at the 
influence that social support and social negativity had on CRP	for the entire sample as well as the 
IV subsample.  We will also use a subset of the SWAN data, including only women who report 
recent (within the previous 12 months) IV.  Finally, for our exploratory aim, we looked at the 
SWAN participant’s perception of IV, and the impact of that perception on CRP.   
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CHAPTER 6 
RESULTS 
Sample Characteristics 
 The data used for this secondary analysis came from the public-use SWAN baseline 
dataset, and initially included information from 3,302 women from seven clinical sites 
participating in the SWAN longitudinal study (Boston, MA; Pittsburgh, PA; Oakland and Los 
Angeles, CA; Detroit, MI; Newark, NJ; and Chicago, IL).  For our analysis,  we eliminated 659 
women who reported an arthritis diagnosis and 18 women who reported a lupus diagnosis, 
because of their known association with CRP elevation (Williams, Harmon, Burlingame, & Du 
Clos, 2005; Windgassen, Funtowicz, Lunsford, Harris, & Mulvagh, 2015).  Fifty-two 
participants were eliminated for missing data.  This left us 71 (2.8%) participants who reported 
having experienced IV within the past 12 months, and 2,502 (97.2%) participants who did not.    
 Table 3 shows the comparison of women reporting IV and women not reporting IV for all 
of the study variables.  There were statistically significant differences for social support (IV M= 
11.27, No IV M=12.45, p=<0.002) and social negativity scores (IV M=10.5, No IV M= 6.96, p= 
<0.000).  There were also significant differences between depression (IV 38% depressed, No IV 
20.5% depressed p=<0.000); income, ; race; and age (IV M=45.18, No IV M=45.78 p= 0.04). 
No significant differences were found between the two groups for mean CRP or BMI, or for 
smoking.   
Analysis for Hypothesis 1 
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 Hypothesis 1 examined whether IV, depression, smoking, and obesity were associated 
with elevated CRP in the SWAN participants as well as in the smaller subset data. Our univariate 
regression analysis (controlling for race, age, and income) demonstrated that IV and smoking 
were not significantly associated with CRP,.  However, depression was significantly associated 
with CRP.  On average, study participants with depression had CRP 0.97 units higher than those 
without depression (95% CI 0.390-1.551, p= 0.001).  BMI was also significantly associated with 
CRP, with participants having an average 0.45 units higher than those with lower BMI (95% CI 
0.281-0.614, p=0.000).  In the full regression model, which included IV, depression, smoking, 
and BMI, while controlling for age, race, and income; only smoking and BMI were statistically 
significant. Smoking had a beta coefficient of 0.631 (95% CI 0.40-1.22, p= 0.037); and BMI a 
coefficient of 0.388 (95% CI 0.356-0.421, p=0.000.  In our hierarchical regression, we first 
tested for multicollinearity, and our Tolerance and VIF values suggested that we did not have 
multicollinearity.  Age, ethnicity, and income were entered initially, explaining 2.8% of the 
variance in CRP.  When the entire model (including IV, BMI, smoking, and depression) was 
used, the total variance explained by the model was increased to 21%, and was statistically 
significant F (7,2481) = 94.99, p=<0.001.  In the final model (IV, BMI, smoking, and 
depression), only BMI was statistically significant (beta= 0.438, p<0.001).  
 We also tested hypothesis 1 on the IV subsample.  While controlling for age, race, and 
income, bi-variate regression showed a statistically significant relationship between BMI and 
CRP, with a BMI beta coefficient of 0.447 (95% CI 0.281-0.614, p=0.000).  In the full regression 
model, only BMI was statistically significant, with a beta coefficient of 0.493 (95% CI 0.319-
0.667, p=0.00).  With hierarchical regression, the same results were generated, demonstrating no 
multicollinearity, with only BMI statistically significant (beta=0.558, p<0.001). Age, ethnicity, 
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and income were entered initially, explaining 6% of the variance in CRP.  When the entire model 
was used, the total variance explained by the model was increased to 36%, and was statistically 
significant F (6, 59) = 5.64, p=<0.001. 
Analysis for Hypothesis 2 
  Hypothesis 2 examined whether social support was related to lower CRP, and whether 
social negativity was related to higher CRP.  Regression analysis of the variables in hypothesis 2 
demonstrated that the association between CRP and social support was statistically significant, 
suggesting that higher levels of social support have a lowering effect of CRP (-0.098 beta 
coefficient) (95% CI -0.170—0.027, P=0.007).  However, in the full regression model containing 
IV, depression, smoking, BMI, and our control variables, social support was no longer 
statistically significant.  Social negativity was not significantly associated with CRP either in 
bivariate regression, or when included in the full model. Using hierarchical regression, neither 
social support nor social negativity reached a level of statistical significance, and the total model 
continued to explain 21% of the variance in CRP. 
 For the IV subsample, neither social support nor social negativity reached a level of 
statistical significance in relationship to CRP with either linear or hierarchical regression.   
Exploratory analysis 
Because of the structure of the IV question, we wondered whether the perception that IV 
was not “upsetting” might be related to CRP levels.  Our exploration of perception of IV on CRP 
showed that there were not statistically significant differences between women who found IV 
“not at all upsetting” and women who found IV “very upsetting” (p=0.31) and CRP (see table 4).  
However, although our results did not reach a level of statistical significance, they demonstrated 
an interesting trend.  Among the women who reported that their IV was “not upsetting”, more 
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women had a high CRP level.  Among the women who reported that they found their IV 
“somewhat upsetting” or “very upsetting” there were more women with low or normal CRP 
levels than with high.  Though the results were not statistically significant, they are interesting, 
and could point to areas of future investigation. 
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CHAPTER 7 
 
DISCUSSION	
  
Although our review of the literature strongly suggests that there are associations 
between IV, depression, BMI, smoking, and CRP, our analysis of this data set did not find these 
relationships.  This raises many questions about possible explanations; but perhaps one of the 
most interesting potential explanations is that our sample only had an IV prevalence rate of 2.8% 
of the SWAN population, whereas research suggests that the rates of IV are closer to 22.1% of 
women experience IV during their lifetime (CDC, 2012).  This extremely low prevalence rate in 
this sample could be explained in a variety of ways.  First, the measure that was used to assess 
IV specified that the IV occurred within the past 12 months.  This would eliminate women who 
had experienced IV outside of this 12-month window, but still might physiologically be 
experiencing the effects.  The National Intimate Partner and Sexual Violence Survey (NISVS) 
survey reported that 35.6% of women had experienced lifetime IV, but only 5.9% within the 
previous 12 months (Black et al., 2011).  The literature demonstrates that childhood abuse is 
associated with disease and inflammation in adulthood, which suggests that abuse can have an 
impact that lasts many years, if not a lifetime (Felitti, Bremner, Walker, Whitfield, Perry, 2006); 
Tursich et al., 2014). Given that abuse suffered as a child can have lifelong implications, it is 
reasonable to think that abuse suffered in adulthood might have similar implications.   
 Secondly, it is possible that women narrowly interpreted the question being asked, 
especially since the time frame given was so constrained.  The question asks if a woman was 
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“slapped, kicked, or otherwise hurt in the past 12 months”.  This does not necessarily take into 
account the other kinds of IV that can be equally damaging to the victim (sexual assault or abuse, 
psychological abuse, economic abuse, stalking, etc.), if the woman only answered yes if she were 
slapped or kicked.  It is estimated that nearly half of all women (48.8%) experience 
psychological aggression, and approximately 10.8 % of women report to being stalked by an 
intimate partner (Black et al., 2011).  Further, it has been demonstrated that women sexually 
assaulted by intimate partners are more likely to experience concurrent physical abuse than 
women who did not know their attacker (55%, 95% CI 49–61); known assailant compared with 
31% (95% CI 26–36) unknown assailant; and 32% (95% CI 26–38; P<.001 acquaintance 
assailant) (Seyller, Denis, Dang, Boraud, Lepresle, Lefèvre, & Chariot, 2016). Perhaps a 
different question, or parameter, would have generated a sample closer to reported prevalence 
rates if the question were defined more broadly.  Many other measures exist that address the 
other kinds of abuse that a woman might experience (stalking, sexual abuse, emotional abuse, 
etc), or might be experiencing, along with the question asked in the SWAN study (Rabin, 
Jennings, Campbell, & Bair-Merritt, 2009).  
 Thirdly, it is important to consider the issue of disclosure, or whether or not a person who 
experiences something—in this case, IV— accurately reports that they have experienced it.  
Research suggests that there are often very low rates of disclosure of information that many 
people consider highly personal including; sexual assault, HIV status, sexual orientation, 
intimate partner violence, and homelessness (Evans, Wertheim, 2002 see also Rhodes, Frankel,  
Levinthal, Prevnoveau, Bailey, & Levinson, 2007; Chen, 2006).  For some, disclosure can result 
in an increased sense of vulnerability, alienation, loss of “normalcy”, financial hardship, and 
relationship losses, making disclosure less likely to occur (Saiki, Lobo, 2011 see also Kahn, 
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Garrison 2009; McDonald, 2008; Montalvo-Liendo, Wardell, Engebretson, & Reininger 2009).  
Further, Saiki and Lobo (2011) state that disclosure exposes the person disclosing the 
information to risk of rejection or negative judgment, also potentially decreasing the rate of 
disclosure (Saiki, Lobo, 2011).   
 Additionally, fewer than half of IV incidents are reported to the police (Greenfeld et al., 
1998).  The most common reasons for not reporting IV to police are that the victim fears 
retaliation, they consider it a private matter, or, they do not believe that police will do anything 
or believe them (Greenfeld et al.,1998).  Even in healthcare settings disclosure of IV is extremely 
low.  Golding et al. (2000) report that fewer than 17.5% of women with IV history report sharing 
their abuse history with a health care provider.  Data from the National Intimate Partner and 
Sexual Violence Survey estimated that, even though over 12 million people (both men and 
women) experienced some form of IV, only 480,000 injuries from these encounters are reported 
to law enforcement, and only 150,000 of these injuries received medical attention (Catalano, 
2013).  It is reasonable to speculate that if women experiencing IV are unwilling or unable to 
disclose IV to law enforcement, and to health care providers, they might also be unwilling or 
unable to disclose their IV experiences to research teams.  
 From a feminist research perspective, it makes sense that there is considerable crossover 
between IV, mental health, and risk behaviors because what is happening to a woman’s body 
impacts her mind and emotions, and informs her actions.  All four variables have been associated 
with CRP, as discussed above.  The literature also discusses the associations between smoking 
and depression, and BMI and depression.  Carpenter and colleagues (2000) demonstrated a 
significant association between obesity and smoking in women.  Mykletun, Overland, Aarø, 
Liabø,  & Stewart, (2008) however found the most significant association between anxiety 
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depression and smoking.  It is likely that many complex relationships exist between these 
variables, and deciding how best to address them in the clinical setting as well as in the research 
environment will likely add to our knowledge about how they interact, how to treat them 
(simultaneously, one at a time, etc), and how they impact health will hopefully lead to improved 
health outcomes.   
 In looking at hypothesis 1, both the SWAN data set and the IV subset demonstrated 
statistically significant associations between BMI and CRP, which is consistent with the 
literature, but the lack of association between IV, smoking, depression in the hierarchical 
regression is not consistent with the literature.  Though there is no simple explanation for these 
results, they do reinforce the importance of weight management as part of overall health.   
 The literature supports the hypothesis that there is an  association between social support 
and social negativity and CRP, but this was also not found in our analyses.    One possible 
explanation is that the scales that were used to measure social support and social negativity did 
not adequately reflect what was actually happening in participant’s lives.  Also, perhaps social 
support is more protective when it is directly related to the IV experience, for example having 
someone to talk to about the IV, which was not assessed in the SWAN data set.  The perception 
that a woman had about the IV might also play a role, as our analysis did not show an association 
between being more bothered by IV and CRP or were less bothered.  Though analysis did not 
reach a level of statistical significance, among women who reported that their IV was “very 
upsetting”, more women had low or normal CRP than high.  Also interesting, though not 
statistically significant, is that among women who reported that they were “not at all bothered” 
by their IV, more had high CRP than normal or low.  This could speak to a weathering effect that 
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might occur in women who have experienced abuse for a long period of time, no longer 
reporting that they are bothered by it, but still experiencing an elevation in CRP.   
 
 
Clinical Implications 
Although we did not find statistically significant relationships  between IV, depression, 
smoking, social support, or social negativity, this research, as a whole, adds to the literature by 
emphasizing to primary care providers (physicians, nurse practitioners, and physician assistants) 
the importance of including questions about IV history in patient assessments and family 
histories.  For patients with multiple vague complaints, providers might benefit from exploring a 
possible IV history in their patients’ pasts and using that information to better guide their care.  
For providers who know of a patient’s IV history, examining the various body systems 
potentially affected might lead to better patient screening, education, and hopefully outcomes. 
Results of our literature review related to CVD and CRP are also useful to consider for 
clinical practice. Research has shown that statin therapy affects LDL and CRP independently, 
and it has been proposed that CRP screening might provide an improved method of targeting 
statin therapy for those who might be at risk for CVD but who have normal LDL levels (Albert 
et al., 2002; Ridker et al. 1999). In Albert et al.’s (2002) primary prevention trial comparing 
pravastatin with placebo, they demonstrated a median CRP level reduction of 16.9% (P<0.001) 
at 24 weeks with no change in CRP levels in the placebo group, with the effect seen as early as 
12 weeks after treatment initiation.  Furthermore, they found no significant association between 
baseline CRP and baseline LDL-cholesterol levels, end of study CRP and end of study LDL, or 
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change in CRP and change in LDL, with the only significant predictor of change in CRP being 
randomization to pravastatin and baseline CRP levels (Albert et al., 2002).    
Some evidence suggests that female-specific interventions might be more effective than 
those that target both men and women, possibly because they can address concerns and stresses 
that might be specific to women, such as greater household responsibilities, lower self-esteem, 
low self-efficacy regarding exercise or transportation, lack of spousal support, etc. (Bjarnason-
Wehrens, Grande, Loewel, Völler, Mittag, 2007).  Several psychosocial risk factors also effect 
women differently than men and are important to keep in mind when talking with patients.  For 
example, hostility and work stress conferred less cardiac risk for women than did marital stress 
and anger suppression.  The ability to identify psychosocial factors associated with elevated 
CVD risk in women can aid in the identification of women in the healthcare setting, as well as 
inform more effective intervention strategies. 
In secondary analysis of the M-HART study of nursing interventions, Cossette, Frasure-
Smith, and Lespérance (2002) found that approaches focused on education and encouragement 
predicted better outcomes for men, but worse outcomes for women.  For women, better 
outcomes occurred when medical professionals listened to concerns about non-cardiac physical 
symptoms and discussed their treatment burden (Cossette et al., 2002).  Depression has been 
consistently associated with increased CVD for both men and women, but psychological 
interventions to treat depression have not benefited women in terms of CVD outcomes (Cossette 
et al., 2002).  While there is a need to explore the ways in which we can improve psychosocial 
interventions for women living with CVD, of utmost importance is the potential to use 
psychosocial interventions in women merely at risk for CVD in the clinical setting.   
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Limitations of the Study 
One of the major limitations of this study is that it does not appear to be representative of 
the general population.  In the SWAN data set, only 2.8% of women reported IV, in contrast to 
extimates in the general population of 22.1% (CDC, 2012), making this sample not 
representative.   
We were also restricted by the very nature that we conducted a secondary analysis, and 
did not have the opportunity to shape the SWAN study.  At the baseline interview, SWAN took a 
very limited approach to IV, asking only about abuse within the previous 12 months.   Assessing 
only current or recent abuse dismisses earlier traumas that impact may current and future health 
outcomes, and it does not take into account the evidence showing that many women who are 
currently in abusive relationships may also have had a history of abuse of some kind (Campbell 
et al., 2008; Scott-Storey, 2011; Cavanaugh et al., 2012).  With it’s very narrow time range for 
IV (past 12 months) the SWAN dataset failed to take into account the potential effect of multiple 
or lifetime traumas in participants, severely limiting the study.   
Directions for Future Research   
Childhood abuse has been demonstrated to be associated with poorer health outcomes for 
many years, but abuse experienced as an adult has not been studied as extensively.   Exploring 
the differences between abuse experienced during childhood vs. abuse experienced in adulthood 
(not just within the previous 12 months) would add to our knowledge of how abuse so negatively 
impacts health, and might how perception of abuse might be a factor.  Children might perceive 
abuse very differently than adults, and this could impact not only treatment of abuse survivors, 
but health implications.   
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Another area of interest for future research includes establishing the prevalence of IV 
history screening in primary care settings as well as barriers to effective screening.  Screening 
women for IV is recommended by many healthcare and health policy organizations including the 
USPSTF, American College of Nurse Midwives, American Academy of Family Physicians 
(Nelson, Bougatsos, & Blazina, 2012; Paterno & Draughon, 2016; American Academy of Family 
Physicians, 2013).  In Golding et al.’s (2000) study of women with severe PMS, although IV 
history was nearly universal, only 17.5% of the participants reported ever having told a health 
care provider about the history. Plichta and Falik (2001) also discussed screening concerns based 
on their data that less than 29% of IV survivors reported having discussed the history with a 
health care provider and that of those few who did, 73% of them brought the history to their 
provider’s attention without having ever been asked.  These studies suggest that screening for a 
history of IV is not universally done in primary care settings, where providers are most likely to 
see women for many of the symptoms and conditions discussed here. 
As discussed above, better screening tools for CVD in women is of critical importance.  
Traditional CVD risk algorithms like the Framingham risk score are less predictive in women 
and tend to underestimate CVD in women (Shaw, Bugiardini, & Merz, 2009).  More novel risk 
factors, such as CRP, improve prediction in women and might be useful in the treatment of 
women.  
Also, the best way to screen women for a history of IV is unclear. Is it preferable to 
discuss the issue in person with patients, or to ask on intake forms?  Should screening be done 
only on intake into a practice, or more frequently?  Would knowledge of IV history influence the 
plan of care and could it improve patient outcomes?   
For clinicians, interventions cannot be utilized for conditions or experiences that they do 
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not know their patient is experiencing.  An interesting next step would be to look at disclosure 
more closely, and look at factors in women that might influence her decision to disclose or not 
disclose IV history to a provider, as well as factors in providers or the health care experience.  
For example, developing a survey asking women if they have experienced IV, if they have told a 
health care provider, and then looking at what influenced that decision (being in a relationship, 
provider gender, time since IV experience, provider race/ethnicity, etc).  Further, I propose that if 
women were aware that IV history could impact their cardiovascular health, they would be more 
likely to disclose abuse history to a healthcare provider, and this would be interesting to research.   
Though much work remains to be done, bringing to light the relationship between IV 
history and a multitude of other health issues can hopefully improve health outcomes and 
satisfaction for both patients and those caring for them. 
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Appendix A 
Tables 
Table 1  
Health Conditions Associated with IV 
Cardiovascular Urologic/ 
Gynecologic 
Gastrointestinal Risk 
Behavior 
Health 
Perception 
*Hypertension 
 
*Hyperlipidemia 
 
*Obesity 
 
*Diabetes 
 
*Premenstrual  
 Syndrome 
*Pelvic pain 
 
*Frequent     
urinary tract 
infections 
 
*Dyspareunia 
 
*Anorgasmia 
 
*Vague 
abdominal pain 
 
*Constipation 
 
*Irritable 
bowel 
syndrome 
*Drug/alcohol 
use 
*Risky sexual 
behavior 
 
* Misc. 
*Poor perception of 
health and 
wellbeing 
 
*Greater use of sick 
days 
 
*High rates of 
healthcare 
utilization 
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Table 2 
Variables and Measures 
VARIABLE MEASURE 
Characteristics of woman 
• Age 
• Race 
• Income/Education Level 
• Initial demographic questions 
Risk Behaviors 
• Smoking 
• BMI 
• Smoking was self reported, by answering 
“yes” to both “have you ever smoked 
regularly” and “ do you currently smoke” 
• Kilograms/square meters   
Mental Health: Depression  • CES-D score >16 = depressed 
IV • “In the last 12 months have you 
experienced the following: slapped, 
kicked, or otherwise hurt by 
husband/partner or someone else 
important to you?”  
Social Support 
Social Negativity 
• 4 item social support scale 0-20 
• 10 item social negativity scale 0-30 
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Table 3 
Sample characteristics 
 
            IV 
           N (%) 
71 (2.8%) 
          No IV 
N  (%) 
2502 (97.2%) 
Significance 
Age, years (M, SD) N=71 
45.18yrs (2.24) 
N=2573 
45.78 yrs (2.68) 
P=0.027 
Race 
Caucasian 
African American 
Japanese 
Chinese 
Hispanic 
 
 
32  (45.1%) 
29 (40.8%) 
3 (4.2%) 
3 (4.2%) 
4 (5.6%) 
 
1215 (47.2%) 
683 (26.5%) 
249 (9.7%) 
219 (8.5%) 
207 (8%) 
 
P=0.04 
Income: Don’t know 
Refused 
Less than $19,999 
 
$20,000- 
$49,999 
 
$50,000- 
$99,999 
 
$100,000 
or more 
3 (4.2%) 
0 
19 (26.8%) 
 
27 (38%) 
 
 
16 (22.5%) 
 
 
6 (8.5%) 
21 (0.8%) 
32 (1.2%) 
327 (12.7%) 
 
846 (32.9%) 
 
 
944 (36.7%) 
 
 
396 (15.4%) 
 
P=0.000 
CRP N=71 M=3.31 (5.5) N=2573  M= 3.5 (6.05) P=0.789 
Depression 
Depressed 
Not depressed 
 
27 (38%) 
40 (56.3%) 
 
528 (20.5%) 
1989 (77.3%) 
P=0.000 
BMI N= 70 M=27.63 
(6.6) 
N=2545 M=27.63 
(6.78)  
P=0.998 
Smoking 
Smoker 
Non-smoker 
 
15 (21.1%) 
56 (78.9%) 
 
408 (15.9%) 
2165 (84.1%) 
P=0.286 
Social Support 
Social Negativity 
N= 71 M=11.27 
(3.58) 
N= 71 M= 10.5 
(5.95) 
N=2572 M= 12.45 
(3.24) 
N=2548 M= 6.96 (4.86) 
P=0.002 
P=0.000 
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Table 4 
 
Perception of IV 
 
Hurt by someone 
close in past year 
Low CRP Normal CRP High CRP Total 
Yes, Not at all 
Upsetting 
0 2 3 5 
Yes, Somewhat 
Upsetting 
12 7 6 25 
Yes, Very 
Upsetting 
14 14 13 41 
Total 26 23 22 71 
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Appendix B 
Conceptual Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S o c i a l  C o n t e x t :  P o s i t i v e  a n d  N e g a t i v e  
				Inter-	Personal	Violence	
			Cardio		Vascular			Disease	
Mental	Health	
Risk	Behaviors	
					CRP	Elevation	
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Appendix C 
Scales and Instruments Used 
 
 CES-D Depression Inventory 
 
 INSTRUCTIONS: For each statement, please place a mark in the column that best 
 describes how you have been feeling in the past week. 
 
  Rarely or 
none of the 
time 
(less than 1 
day) 
Some or a 
little of the 
time 
(1 – 2 days) 
Occasionally 
or a moderate 
amount of the 
time 
(3 – 4 days) 
Most or all of 
the time 
(5 – 7 days) 
1. I was 
bothered 
by things 
that 
usually 
don’t 
bother me. 
 
 
 
 
 
 
 
 
 
2.  I did not 
feel like 
eating; my 
appetite 
was poor. 
 
 
 
 
 
 
 
 
 
3. I felt that I 
could not 
shake off 
the 
blues, 
even with 
the help 
from 
family or 
friends. 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. I felt that I     
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was just as 
good as 
other 
people. 
 
5. I had 
trouble 
keeping 
my mind 
on what 
I was 
doing. 
 
    
6. I felt 
depressed. 
 
    
7. I felt that 
everything 
I did was 
an effort. 
 
    
8. I felt 
hopeful 
about the 
future. 
 
    
9. I thought 
my life 
had been a 
failure. 
 
    
10. I felt 
fearful. 
 
    
11. My sleep 
was 
restless. 
 
    
12. I was 
happy. 
 
    
13. I talked 
less than 
usual. 
 
    
14. I felt     
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lonely. 
 
15. People 
were 
unfriendly
. 
 
    
16. I enjoyed 
life. 
 
    
17. I had 
crying 
spells. 
 
    
18. I felt sad. 
 
    
19. I felt that 
people 
dislike 
me. 
 
    
20. I could not 
get 
“going”. 
 
    
 
 
 Total:_______/60 (CESDT)                    
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Social negativity Scale 
 
 
The following section will ask you about personal feelings.  These questions are important, as 
our feelings may directly affect our health or influence how we respond to health issues. 
In your day-to-day life have you had the following experiences; Often, Sometimes, Rarely, or 
Never. (CIRCLE ONE ANSWER FOR EACH QUESTION) 
 
  Often Sometimes Rarely Never 
a. You are treated with less courtesy than other people     
b. You are treated with less respect than other people     
c. You receive poorer service than other people at 
restaurants or stores 
    
d. People act as if they think you are not smart     
e. People act as if they are afraid of you     
f. People act as if they think you are dishonest     
g. People act as if they’re better than you are     
h. You or your family members are called names or 
insulted 
    
i. You are threatened or harassed     
j. People ignore you or act as if you are not there     
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Social Support Scale 
 
The next few question focus on some other personal aspects of your life. 
[HAND RESPONDENT CARD “A”] People sometimes look to others for companionship, 
assistance, or other types of support.  How often is each of the following kinds of support 
available to you if you need it?  
  None of the 
time 
A little of 
the time 
Some of 
the time 
Most of the 
time 
All of the 
time 
a. Someone you can 
count on to listen to 
you when you need 
to talk 
     
b. Someone to take 
you to the doctor if 
you needed it 
     
c. Someone to confide 
in or talk to about 
yourself of your 
problems 
     
d. Someone to help 
with daily chores if 
you were sick 
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IV Assessment 
 
During the last 12 months, have you experienced any of the following: If you have not, circle 1 
(NO).  If you have and it was not at all upsetting, circle 2.  If you have and it was somewhat 
upsetting circle 3.  If you have and it was very upsetting circle 4.  Please circle one answer for 
each question. 
 
 
  NO YES 
Not at all 
upsetting 
YES 
Somewhat 
upsetting 
YES 
Very 
upsetting 
a. Slapped, kicked, or otherwise hurt by 
husband/partner or someone else important to 
you 
 
   1 
 
      2 
 
      3 
 
     4 
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